Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01794403 · ClinicalTrials.gov registry record · NA
Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer
A NA study of Prostate Cancer, sponsored by University of Miami.
- Active
- Registry status
- NA
- Development phase
- 161
- Enrollment target
- 3
- Study locations
NCT01794403 is a NA study of Prostate Cancer that is active but no longer recruiting, run by University of Miami. The registered enrollment target is 161 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (74% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT01794403, a NA study of Prostate Cancer, is active but no longer recruiting, sponsored by University of Miami.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 161 participants
- Enrollment target
- 3
- Study locations
Study Summary
Accelerated Hypofractionation Radiotherapy for prostate cancer of 36.25 Gy delivered in 5 fractions will not be inferior to the standard treatment of 70.2 Gy given in 26 fractions with respect to four-year biochemical failure (PSA failure) by Phoenix definition post-treatment completion.
Conditions Studied
Interventions
- RADIATION Extended Hypofractionation Radiotherapy
- RADIATION Accelerated Hypofractionation Radiotherapy
Study Locations (3)
Florida
- University of Miami - Miami
New South Wales
- Northern Sydney Local Health District - Royal North Shore Hospital - St Leonards
Turin
- A.O.U. Città della Salute e della Scienza di Torino - University Hospital Trust of Turin - Turin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2013-04-04 |
| Est. Completion | 2027-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01794403
The ClinicalTrials.gov registry entry for NCT01794403 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 161 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (74% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Extended Hypofractionation Radiotherapy is the first listed.
NCT01794403 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, New South Wales, Turin.
Frequently Asked Questions
What is clinical trial NCT01794403 about?
NCT01794403 is a clinical study titled "Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer". Accelerated Hypofractionation Radiotherapy for prostate cancer of 36.25 Gy delivered in 5 fractions will not be inferior to the standard treatment of 70.2 Gy given in 26 fractions with respect to four-year biochemical failure (PSA failure) by Phoenix definition post-treatment completion.
What is the current status of trial NCT01794403?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 161 participants. The study started on 2013-04-04. Estimated completion is 2027-02-01.
What conditions does trial NCT01794403 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT01794403?
The interventions under investigation include: Extended Hypofractionation Radiotherapy (RADIATION), Accelerated Hypofractionation Radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT01794403?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01794403 being conducted?
This trial has 3 study locations across Florida, New South Wales, Turin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.